Edition:
United States

Sustainable Business

Breakingviews

Breakingviews - Breakdown: The scramble for a Covid-19 vaccine

Pharmaceutical groups such as AstraZeneca and Pfizer may soon get regulators’ blessing for new coronavirus inoculations. A successful vaccine could ease a crisis that the Congressional Budget Office estimates will cost the United States alone some $8 trillion. Yet doubts over efficacy will linger, and manufacturing challenges mean poorer countries may have to wait. The reward for drugmakers is equally uncertain.

Video

Featured Topics

More Sustainability Coverage

BNP Paribas issues Australia's first climate-linked bond

BNP Paribas issued Australia's first green bond linked to the performance of an index tracking companies tipped to benefit from the country's transition into a low-carbon economy, aiming to bridge a gap in sustainable investment products.

2019 Thomson Reuters Sustainability Report

The Pathway to Leadership for Carbon Intensive Businesses

Download now »

Interactive

Reuters Sustainability: Autos

Business model transformation and decarbonization within the autos sector

Executive Perspectives

This section combines expertise from Thomson Reuters and valued external Partners